120 related articles for article (PubMed ID: 15542593)
1. The dileucine motif at the COOH terminus of human multidrug resistance P-glycoprotein is important for folding but not activity.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2005 Jan; 280(4):2522-8. PubMed ID: 15542593
[TBL] [Abstract][Full Text] [Related]
2. Processing mutations located throughout the human multidrug resistance P-glycoprotein disrupt interactions between the nucleotide binding domains.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2004 Sep; 279(37):38395-401. PubMed ID: 15247215
[TBL] [Abstract][Full Text] [Related]
3. Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Apr; 278(16):13603-6. PubMed ID: 12609990
[TBL] [Abstract][Full Text] [Related]
4. Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Dec; 278(50):50136-41. PubMed ID: 14522974
[TBL] [Abstract][Full Text] [Related]
5. Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70.
Kapoor K; Bhatnagar J; Chufan EE; Ambudkar SV
J Biol Chem; 2013 Nov; 288(45):32622-32636. PubMed ID: 24064216
[TBL] [Abstract][Full Text] [Related]
6. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein.
Loo TW; Clarke DM
Biochemistry; 1994 Nov; 33(47):14049-57. PubMed ID: 7947814
[TBL] [Abstract][Full Text] [Related]
7. Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane.
Loo TW; Clarke DM
J Biol Chem; 1999 Dec; 274(50):35388-92. PubMed ID: 10585407
[TBL] [Abstract][Full Text] [Related]
8. Insertion of an arginine residue into the transmembrane segments corrects protein misfolding.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2006 Oct; 281(40):29436-40. PubMed ID: 16926162
[TBL] [Abstract][Full Text] [Related]
9. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
[TBL] [Abstract][Full Text] [Related]
10. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities.
Loo TW; Clarke DM
J Biol Chem; 1995 Sep; 270(37):21449-52. PubMed ID: 7665554
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2.
Polgar O; Ierano C; Tamaki A; Stanley B; Ward Y; Xia D; Tarasova N; Robey RW; Bates SE
Biochemistry; 2010 Mar; 49(10):2235-45. PubMed ID: 20088606
[TBL] [Abstract][Full Text] [Related]
12. Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 1994 Mar; 269(10):7243-8. PubMed ID: 7907326
[TBL] [Abstract][Full Text] [Related]
13. The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface.
Loo TW; Clarke DM
J Biol Chem; 1999 Aug; 274(35):24759-65. PubMed ID: 10455147
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of functionally important elements in the multidrug resistance protein 1 COOH-terminal region.
Westlake CJ; Payen L; Gao M; Cole SP; Deeley RG
J Biol Chem; 2004 Dec; 279(51):53571-83. PubMed ID: 15459206
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Oct; 278(41):39706-10. PubMed ID: 12909621
[TBL] [Abstract][Full Text] [Related]
17. Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane.
Loo TW; Clarke DM
J Biol Chem; 2000 Dec; 275(50):39272-8. PubMed ID: 11013259
[TBL] [Abstract][Full Text] [Related]
18. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
19. Identification of residues in the drug translocation pathway of the human multidrug resistance P-glycoprotein by arginine mutagenesis.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2009 Sep; 284(36):24074-87. PubMed ID: 19581304
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants regulating expression of the high affinity leukotriene B4 receptor: involvement of dileucine motifs and alpha-helix VIII.
Gaudreau R; Beaulieu ME; Chen Z; Le Gouill C; Lavigne P; Stanková J; Rola-Pleszczynski M
J Biol Chem; 2004 Mar; 279(11):10338-45. PubMed ID: 14688279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
